Dingdang Health (09886) Sets 20 March 2026 Board Meeting to Review FY 2025 Results and Final-Dividend Proposal

Bulletin Express03-10

Dingdang Health Technology Group Ltd. (09886) announced that its board of directors will convene on 20 March 2026 to review and approve the Group’s audited annual results for the financial year ended 31 December 2025. The meeting will also consider a recommendation on the payment of a final dividend, if any.

The notice, dated 10 March 2026, was signed by Chairman Yang Wenlong. The current Board comprises five executive directors (Yang Wenlong, Yang Yibin, Xu Ning, Yu Qinglong and Meng Fanzhou), one non-executive director (Li Chuheng) and three independent non-executive directors (Zhang Shouchuan, Dr. Fan Zhenhong and Jiang Shan).

Investors will receive disclosure of the FY 2025 financial statements and any dividend proposal following the Board’s deliberations on the specified date.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1122236964?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-10 18:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122236964","market":"us","top_or_hot":-1,"title":"Dingdang Health (09886) Sets 20 March 2026 Board Meeting to Review FY 2025 Results and Final-Dividend Proposal","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. (09886) announced that its board of directors will convene on 20 March 2026 to review and approve the Group’s audited annual results for the financial year ended 31 December 2025. The meeting will also consider a recommendation on the payment of a final dividend, if any.</p>\n<p>The notice, dated 10 March 2026, was signed by Chairman Yang Wenlong. The current Board comprises five executive directors (Yang Wenlong, Yang Yibin, Xu Ning, Yu Qinglong and Meng Fanzhou), one non-executive director (Li Chuheng) and three independent non-executive directors (Zhang Shouchuan, Dr. Fan Zhenhong and Jiang Shan).</p>\n<p>Investors will receive disclosure of the FY 2025 financial statements and any dividend proposal following the Board’s deliberations on the specified date.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health (09886) Sets 20 March 2026 Board Meeting to Review FY 2025 Results and Final-Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health (09886) Sets 20 March 2026 Board Meeting to Review FY 2025 Results and Final-Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-10 18:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. (09886) announced that its board of directors will convene on 20 March 2026 to review and approve the Group’s audited annual results for the financial year ended 31 December 2025. The meeting will also consider a recommendation on the payment of a final dividend, if any.</p>\n<p>The notice, dated 10 March 2026, was signed by Chairman Yang Wenlong. The current Board comprises five executive directors (Yang Wenlong, Yang Yibin, Xu Ning, Yu Qinglong and Meng Fanzhou), one non-executive director (Li Chuheng) and three independent non-executive directors (Zhang Shouchuan, Dr. Fan Zhenhong and Jiang Shan).</p>\n<p>Investors will receive disclosure of the FY 2025 financial statements and any dividend proposal following the Board’s deliberations on the specified date.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1122236964","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122236964","pubTimestamp":1773137036,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. (09886) announced that its board of directors will convene on 20 March 2026 to review and approve the Group’s audited annual results for the financial year ended...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康(09886)定于2026年3月20日召开董事会会议，审阅2025财年业绩及末期股息建议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. (09886) announced that its board of directors will convene on 20 March 2026 to review and approve the Group’s audited annual results for the financial year ended 31 December 2025. The meeting will also consider a recommendation on the payment of a final dividend, if any.\nThe notice, dated 10 March 2026, was signed by Chairman Yang Wenlong. The current Board comprises five executive directors (Yang Wenlong, Yang Yibin, Xu Ning, Yu Qinglong and Meng Fanzhou), one non-executive director (Li Chuheng) and three independent non-executive directors (Zhang Shouchuan, Dr. Fan Zhenhong and Jiang Shan).\nInvestors will receive disclosure of the FY 2025 financial statements and any dividend proposal following the Board’s deliberations on the specified date.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1122236964","isCrawlerRequest":true}